• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非裔美国男性是否需要单独的前列腺癌筛查指南?

Do African-American men need separate prostate cancer screening guidelines?

作者信息

Shenoy Divya, Packianathan Satyaseelan, Chen Allen M, Vijayakumar Srinivasan

机构信息

University of Mississippi Medical School, Jackson, MS, USA.

University of Mississippi Medical Center, 2500 North State Street, 39216-4505, Jackson, MS, USA.

出版信息

BMC Urol. 2016 May 10;16(1):19. doi: 10.1186/s12894-016-0137-7.

DOI:10.1186/s12894-016-0137-7
PMID:27165293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4862049/
Abstract

BACKGROUND

In 2012, the United States Preventative Services Task Force issued new guidelines recommending that male U.S. residents, irrespective of race, no longer be screened for prostate cancer. In African American men, the incidence of prostate cancer is almost 60 % higher and the mortality rate is two to three times greater than in Caucasians. The purpose of this study is to reduce African American men's prostate cancer burden by demonstrating they need separate screening guidelines.

METHODS

We performed a PubMed search using the keywords: African American, Prostate cancer, Outcomes, Molecular markers, Prostate-specific Antigen velocity, PSA density, and to derive data relevant to our hypothesis.

RESULTS

In our literature review, we identified several aspects of prostate cancer that are different in Caucasian and African American men. These included prostate cancer incidence and outcome, the clinical course of the disease, serum PSA levels, genetic differences, and social barriers. It's also important to note that the USPSTF guidelines were based on two studies, one of which reported that only 4 % of its participants were African American. The other did not report demographic information, but used participants from seven European countries with small African American populations.

CONCLUSION

Given the above, we conclude that separate prostate cancer screening guidelines are greatly necessary to help save the lives of African Americans.

摘要

背景

2012年,美国预防服务工作组发布了新指南,建议美国男性居民,无论种族如何,均不再进行前列腺癌筛查。在非裔美国男性中,前列腺癌的发病率比白种人高近60%,死亡率是白种人的两到三倍。本研究的目的是通过证明非裔美国男性需要单独的筛查指南来减轻他们的前列腺癌负担。

方法

我们使用关键词“非裔美国人”“前列腺癌”“结果”“分子标志物”“前列腺特异性抗原速度”“PSA密度”在PubMed上进行搜索,以获取与我们假设相关的数据。

结果

在我们的文献综述中,我们确定了前列腺癌在白种人和非裔美国男性中存在差异的几个方面。这些方面包括前列腺癌的发病率和结果、疾病的临床过程、血清PSA水平、基因差异以及社会障碍。还需要注意的是,美国预防服务工作组的指南基于两项研究,其中一项研究报告称其参与者中只有4%是非裔美国人。另一项研究没有报告人口统计学信息,但使用了来自七个欧洲国家且非裔美国人群体较少的参与者。

结论

鉴于上述情况,我们得出结论,非常有必要制定单独的前列腺癌筛查指南,以帮助挽救非裔美国人的生命。

相似文献

1
Do African-American men need separate prostate cancer screening guidelines?非裔美国男性是否需要单独的前列腺癌筛查指南?
BMC Urol. 2016 May 10;16(1):19. doi: 10.1186/s12894-016-0137-7.
2
Prostate Cancer Screening Guidelines for African American Veterans: A New Perspective.美国黑人退伍军人前列腺癌筛查指南:新视角。
J Natl Med Assoc. 2020 Oct;112(5):448-453. doi: 10.1016/j.jnma.2018.10.010. Epub 2018 Nov 6.
3
Rates of clinically significant prostate cancer in African Americans increased significantly following the 2012 US Preventative Services Task Force recommendation against prostate specific antigen screening: A Single Institution Retrospective Study.2012 年美国预防服务工作组建议反对前列腺特异性抗原筛查后,非裔美国人中临床显著前列腺癌的发生率显著增加:一项单机构回顾性研究。
Int J Clin Pract. 2020 Feb;74(2):e13447. doi: 10.1111/ijcp.13447. Epub 2019 Dec 6.
4
Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.美国黑人男性前列腺癌基金会筛查指南
NEJM Evid. 2024 May;3(5):EVIDoa2300289. doi: 10.1056/EVIDoa2300289. Epub 2024 Apr 23.
5
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.前列腺癌筛查:美国预防服务工作组推荐声明。
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.
6
African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.患有前列腺癌的非裔美国男性比白人男性的肿瘤体积更大,尽管他们的血清前列腺特异性抗原并无差异。
Can J Urol. 2018 Feb;25(1):9193-9198.
7
Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.种族、遗传的西非血统以及前列腺特异性抗原在前列腺癌前瞻性筛查高危男性中的预测作用
Cancer Prev Res (Phila). 2009 Mar;2(3):244-50. doi: 10.1158/1940-6207.CAPR-08-0150. Epub 2009 Feb 24.
8
Physician-patient discussions with african american men about prostate cancer screening.医生与非裔美国男性关于前列腺癌筛查的讨论。
Am J Mens Health. 2008 Jun;2(2):156-64. doi: 10.1177/1557988307309323. Epub 2007 Dec 5.
9
Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.非裔美国男性和白种男性有无家族病史的前列腺癌特异性临床数据的招募策略及比较。
Prostate Cancer Prostatic Dis. 2008;11(3):274-9. doi: 10.1038/pcan.2008.5. Epub 2008 Feb 12.
10
African Americans' Perceptions of Prostate-Specific Antigen Prostate Cancer Screening.非裔美国人对前列腺特异性抗原前列腺癌筛查的看法。
Health Educ Behav. 2015 Aug;42(4):539-44. doi: 10.1177/1090198114566453. Epub 2015 Jan 23.

引用本文的文献

1
Barriers and sources of information in prostate cancer screening at a South African hospital.南非一家医院前列腺癌筛查中的信息障碍与信息来源
J Public Health Afr. 2025 Apr 12;16(1):666. doi: 10.4102/jphia.v16i1.666. eCollection 2025.
2
Fast prostate MRI vs. conventional multiparametric prostate MRI: comparison and outcomes.快速前列腺磁共振成像与传统多参数前列腺磁共振成像的比较及结果
Abdom Radiol (NY). 2025 Apr 7. doi: 10.1007/s00261-025-04918-8.
3
Unveiling Racial Disparities in Localized Prostate Cancer: A Systems-Level Exploration of the lncRNA Landscape.揭示局限性前列腺癌中的种族差异:lncRNA图谱的系统层面探索
Genes (Basel). 2025 Feb 17;16(2):229. doi: 10.3390/genes16020229.
4
Human immune system: Exploring diversity across individuals and populations.人类免疫系统:探索个体和群体间的多样性。
Heliyon. 2025 Jan 13;11(2):e41836. doi: 10.1016/j.heliyon.2025.e41836. eCollection 2025 Jan 30.
5
Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa.确定赞比亚前列腺癌的国家研究重点:采用德尔菲法制定撒哈拉以南非洲地区的综合癌症政策
BMJ Oncol. 2024 May 8;3(1):e000172. doi: 10.1136/bmjonc-2023-000172. eCollection 2024.
6
Exploring prostate-specific antigen (PSA) Testing rates and screening disparities in the all of us dataset.在“我们所有人”数据集中探索前列腺特异性抗原(PSA)检测率及筛查差异。
Urol Oncol. 2025 Mar;43(3):194.e1-194.e8. doi: 10.1016/j.urolonc.2024.11.011. Epub 2024 Nov 30.
7
Advancements in Biomarkers of Prostate Cancer: A Review.前列腺癌生物标志物的研究进展:综述。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241290029. doi: 10.1177/15330338241290029.
8
Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.前列腺癌:遗传学、当前生物标志物和个体化治疗的综述。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70016. doi: 10.1002/cnr2.70016.
9
The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men.影响非裔美国男性前列腺癌差异的可改变风险因素的复杂相互作用。
Nat Rev Urol. 2024 Jul;21(7):422-432. doi: 10.1038/s41585-023-00849-5. Epub 2024 Feb 2.
10
Linking African ancestral substructure to prostate cancer health disparities.将非洲祖先亚结构与前列腺癌健康差异联系起来。
Sci Rep. 2023 Nov 27;13(1):20909. doi: 10.1038/s41598-023-47993-x.

本文引用的文献

1
The Relationship Between Education and Prostate-Specific Antigen Testing Among Urban African American Medicare Beneficiaries.城市中非洲裔美国医保受益人群中教育与前列腺特异性抗原检测之间的关系。
J Racial Ethn Health Disparities. 2015 Jun;2(2):176-83. doi: 10.1007/s40615-014-0061-z. Epub 2014 Oct 31.
2
African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance.格里森评分3+3=6的非裔美国男性前列腺癌患者产生的前列腺特异性抗原比白人男性少:对主动监测的潜在影响。
J Urol. 2016 Feb;195(2):301-6. doi: 10.1016/j.juro.2015.08.089. Epub 2015 Sep 2.
3
Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation.非裔美国男性更早进行前列腺特异性抗原检测——该建议的临床依据
Urol Oncol. 2015 Jul;33(7):330.e9-17. doi: 10.1016/j.urolonc.2015.03.018. Epub 2015 Apr 30.
4
Life Expectancy and Treatment Choice for Men with High-risk Prostate Cancer.高危前列腺癌男性的预期寿命与治疗选择
Eur Urol. 2015 Jul;68(1):59-60. doi: 10.1016/j.eururo.2015.01.006. Epub 2015 Mar 23.
5
Impact of race on selecting appropriate patients for active surveillance with seemingly low-risk prostate cancer.种族对选择貌似低危前列腺癌行主动监测合适患者的影响。
Urology. 2015 Feb;85(2):436-40. doi: 10.1016/j.urology.2014.09.065.
6
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
7
A genetic-based approach to personalized prostate cancer screening and treatment.一种基于基因的个性化前列腺癌筛查与治疗方法。
Curr Opin Urol. 2015 Jan;25(1):53-8. doi: 10.1097/MOU.0000000000000130.
8
Integrative genomic analysis for the discovery of biomarkers in prostate cancer.用于发现前列腺癌生物标志物的综合基因组分析。
Biomark Insights. 2014 Jun 29;9:39-51. doi: 10.4137/BMI.S13729. eCollection 2014.
9
New recommendations in prostate cancer screening and treatment.前列腺癌筛查与治疗的新建议。
JAAPA. 2014 Aug;27(8):14-20; quiz 26. doi: 10.1097/01.JAA.0000451872.86566.bf.
10
Biopsy criteria for determining appropriateness for active surveillance in the modern era.在现代时代,活检标准用于确定是否适合主动监测。
Urology. 2014 Apr;83(4):869-74. doi: 10.1016/j.urology.2013.12.054.